ROSIGLITAZONE | ROSIGLITAZONE | ATC A10BG02 ATC A10BD04 ATC A10BD03
METABOLISM THIAZOLIDINEDIONE ANTIDIABETIC AGENT HYPOGLYCEMIC AGENTS ANTAGONIST TREATMENT OF TYPE 2 DIABETES | ORAL | Cmax 1.67 MICROMOLAR F 99 PERCENT VD 17.6 LITER PPB 99.8 PERCENT Cl 3.03 LITER / HOUR HT 3.5 HOUR SOLUBILITY SOLUBLE IN A BUFFERED AQUEOUS SOLUTION WITH PH 5 OF 2.3 BUT DECREASES WITH INCREASING PH | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONIST CHEMBL235 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA P37231 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR1 NR1C NR1C3 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |